Status:
COMPLETED
The Effect of Whole Blood Viscosity on Contrast-Induced Nephropathy Development in Patients Undergoing Percutaneous Coronary Intervention
Lead Sponsor:
Bursa Postgraduate Hospital
Conditions:
Percutaneous Coronary Intervention Patients
Eligibility:
All Genders
18-90 years
Brief Summary
In our study, we aimed to investigate how whole blood viscosity (WBV) affects the development of contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary intervention (PCI).
Detailed Description
In our study, 500 patients who applied to the cardiology clinic and underwent PCI for elective procedure, ST segment elevation myocardial infarction (STEMI), and non-STEMI were prospectively included....
Eligibility Criteria
Inclusion
- patients between ages 18 and 90
- underwent PCI in our hospital between
Exclusion
- Patients with chronic kidney disease (CKD) who underwent hemodialysis or peritoneal dialysis
- Patients who underwent to coronary bypass surgery within 48 h were excluded from the study.
Key Trial Info
Start Date :
July 10 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2017
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04703049
Start Date
July 10 2017
End Date
November 30 2017
Last Update
August 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bursa Yüksek İhtisas Hastanesi
Bursa, None Selected, Turkey (Türkiye), 16320